Spots Global Cancer Trial Database for Application of Megavoltage Imaging to Reduce Artifact After Seed Implants
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Application of Megavoltage Imaging to Reduce Artifact After Seed Implants
Official Title: Application of Megavoltage Imaging to Reduce Artifact Following Interstitial Seed Implants for Prostate Adenocarcinoma
Study ID: NCT01810627
Conditions
Interventions
Study Description
Brief Summary: This is a non-randomized study to evaluate the utility of MVCT as a quality assurance measure in patients treated with interstitial permanent seed implants for low and intermediate risk prostate cancer. All patients will received the same standard of care treatment but will receive an additinoal CT image of the prostate.
Detailed Description:
Eligibility
Minimum Age: 50 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: MALE
Healthy Volunteers: No
Locations
Markey Cancer Center, Lexington, Kentucky, United States
Contact Details
Name: William St. Clair, MD
Affiliation: Lucille P. Markey Cancer Center at University of Kentucky
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
